Home Cart Sign in  
Chemical Structure| 165668-41-7 Chemical Structure| 165668-41-7

Structure of Indisulam
CAS No.: 165668-41-7

Chemical Structure| 165668-41-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Indisulam is a carbonic anhydrase inhbitor and a synthetic sulfonamide targeting the G1 phase of the cell cycle.

Synonyms: E 7070

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Indisulam

CAS No. :165668-41-7
Formula : C14H12ClN3O4S2
M.W : 385.85
SMILES Code : O=S(C1=CC=C(S(=O)(N)=O)C=C1)(NC2=CC=CC3=C2NC=C3Cl)=O
Synonyms :
E 7070
MDL No. :MFCD00945325
InChI Key :SETFNECMODOHTO-UHFFFAOYSA-N
Pubchem ID :216468

Safety of Indisulam

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03485950 Other Infectious Diseases Phase 2 Recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       iraad@mdanderson.org Less <<
NCT00165867 Colorectal Cancer Phase 2 Completed - France ... More >> Hôpitaux Civils de Colmar Colmar, France, F- 68024 CRLC Val d'Aurelle Montpellier, France, F-34298 Centre Antoine Lacassagne Nice, France, F-06189 United Kingdom Aberdeen Royal Infirmary Aberdeen, United Kingdom, AB25 2ZN Beatson Oncology Centre Glasgow, United Kingdom, G11 6NT Cookridge Hospital Leeds, United Kingdom, LS16 6QB Leicester Royal Infirmary Leicester, United Kingdom, LE1 5WW Less <<
NCT00059735 Kidney Neoplasms ... More >> Carcinoma, Renal Cell Adenocarcinoma, Renal Cell Less << Phase 2 Completed - United States, California ... More >> Sacramento, California, United States, 95817 United States, New York Bronx, New York, United States, 10466 New York, New York, United States, 10021 New York, New York, United States, 10032 France Villejuif Cedex, France, 94805 Less <<
NCT00080197 Breast Neoplasms ... More >> Metastases Less << Phase 2 Completed - -
NCT01692197 - Completed - -
NCT00165854 Colorectal Cancer (CRC) Phase 2 Completed - France ... More >> Centre Léon Bérard Lyon, France, F-69373 Institut Curie Paris, France, F-75005 Germany Universitätsklinikum der GHS-Essen Essen, Germany, D-45122 Netherlands Netherlands Cancer Institute Amsterdam, Netherlands, 1066 CX Less <<
NCT00014625 Melanoma (Skin) Phase 2 Completed - Austria ... More >> Kaiser Franz Josef Hospital Vienna, Austria, A-1100 Belgium Institut Jules Bordet Brussels, Belgium, 1000 France Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre Leon Berard Lyon, France, 69373 Centre Eugene Marquis Rennes, France, 35064 Germany Medizinische Hochschule Hannover Hannover, Germany, D-30625 Italy Istituto Nazionale per lo Studio e la Cura dei Tumori Naples, Italy, 80131 Norway Norwegian Radium Hospital Oslo, Norway, N-0310 Portugal Instituto Portugues de Oncologia de Francisco Gentil Lisbon, Portugal, 1093 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Royal Marsden NHS Trust London, England, United Kingdom, SW3 6JJ Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT01692197 Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00003981 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - Austria ... More >> Innsbruck Universitaetsklinik Innsbruck, Austria, A-6020 Kaiser Franz Josef Hospital Vienna, Austria, A-1100 Belgium Institut Jules Bordet Brussels, Belgium, B-1000 Ludwig Institute for Cancer Research Brussels, Belgium, B-1200 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Denmark Herlev Hospital - University Hospital of Copenhagen Copenhagen, Denmark, DK-2730 France Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre Leon Berard Lyon, France, 69373 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Institut Claudius Regaud Toulouse, France, 31052 Institut Gustave Roussy Villejuif, France, F-94805 Germany Universitaetsklinikum Essen Essen, Germany, D-45122 Netherlands Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1001HV Antoni van Leeuwenhoekhuis Amsterdam, Netherlands, 1066 CX Academisch Ziekenhuis Groningen Groningen, Netherlands, 9700 RB University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Erasmus University Medical Center Rotterdam, Netherlands, 3008 EA Norway Norwegian Radium Hospital Oslo, Norway, N-0310 Switzerland University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 United Kingdom Newcastle General Hospital Newcastle Upon Tyne, England, United Kingdom, NE4 6BE Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT00003976 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - Austria ... More >> Innsbruck Universitaetsklinik Innsbruck, Austria, A-6020 Kaiser Franz Josef Hospital Vienna, Austria, A-1100 Belgium Institut Jules Bordet Brussels, Belgium, 1000 Ludwig Institute for Cancer Research-Brussels Branch Brussels, Belgium, B-1200 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Denmark Herlev Hospital - University Hospital of Copenhagen Herlev, Denmark, DK-2730 France Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre Leon Berard Lyon, France, 69373 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Institut Claudius Regaud Toulouse, France, 31052 Institut Gustave Roussy Villejuif, France, F-94805 Germany Universitaetsklinik und Strahlenklinik - Essen Essen, Germany, D-45122 Klinikum Nurnberg Nuremberg (Nurnberg), Germany, D-90419 Netherlands Antoni van Leeuwenhoekhuis Amsterdam, Netherlands, 1066 CX Academisch Ziekenhuis der Vrije Universiteit Amsterdam, Netherlands, 1117 MB Academisch Ziekenhuis Groningen Groningen, Netherlands, 9713 EZ University Medical Center Nijmegen Nijmegen, Netherlands, NL-6252 HB Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Norway Norwegian Radium Hospital Oslo, Norway, N-0310 Switzerland University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Kantonsspital - Saint Gallen Saint Gallen, Switzerland, CH-9007 United Kingdom Newcastle General Hospital Newcastle Upon Tyne, England, United Kingdom, NE4 6BE Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ C.R.C. Beatson Laboratories Glasgow, Scotland, United Kingdom, G61 1BD Less <<
NCT00165880 Metastatic Breast Cancer Phase 2 Terminated(This study was stop... More >>ped prematurely due to lack of efficacy.) Less << - Germany ... More >> Charite Universitatsmedizin Berlin Berlin, Germany, D-12200 Stadt Kliniken Frankfurt-Hochst Frankfurt, Germany, D-65929 IORC Gmbh Hamburg, Germany, D-22081 Medizinische Klinik und Poliklinik Mainz, Germany, D-55101 Zentrum fur Innere Medizin Hamatologie / Onkologie Stuttgart, Germany, D-70376 Italy Ospedali Ruiniti Bergamo, Italy, I-24128 Ospedale S. Maria Annunzialata Firenze, Italy, I-50011 Ospedale Morgagni-Pierantoni Forli, Italy, I-47100 IST Istituto nazionale per la Ricerca Genova, Italy, I-16132 Palilinico Universitano Palermo, Italy, I-90127 Azienda Ospedaliera Pisana Pisa, Italy, I-56126 A.O. Arciospedate S. Maria Nuova Reggio Emilia, Italy, I-42100 Ospedale San Filippo Neri Roma, Italy, I-00135 Russian Federation Arkhangelsk Regional Clinical Oncology Center Arkhangelsk, Russian Federation, 163045 Chelyabinsk Regional Oncology Center Chelyabinsk, Russian Federation, 454087 Krasnodar City Oncology Center Krasnodar, Russian Federation, 350040 Leningrad Regional Oncology Center Kuzmolovo, Russian Federation, 188663 Hertzen Research Institute of Oncology Moscow, Russian Federation, 125284 Semashko Central Clinical Hospital Moscow, Russian Federation, 129128 Rostov Oncology Research Institute Rostov-on-Don, Russian Federation, 344037 Petrov Research Institute of Oncology St. Petersburg, Russian Federation, 197758 Spain Hospital Universiatio de Guadalajara Guadalajara, Spain, I-19002 Centro Oncologico Regional de Galicia La Coruna, Spain, E-15009 Hospital Unicersaitario de La Princesa Madrid, Spain, E-28006 Centro Oncologico Anderson Internacional Madrid, Spain, E-28033 Hospital Clinico U. Virgen de la Victoria Malaga, Spain, E-29010 Hospital Clinico Universitario Lozano Blesa Zaragoza, Spain, E-50009 Hospital Clinico Universitario Lozano Blesa Zaragoza, Spain, I-19002 United Kingdom Cookridge Hospital Leeds, United Kingdom, LS16 6QB St Bartholomew's Hospital London, United Kingdom, EC1A 7BE Christie Hospital NHS Trust Manchester, United Kingdom, M20 4GJ Mount Vernon Cancer Centre Northwood, United Kingdom, HA1 2RN South West Wales Cancer Institute Swansea, United Kingdom, SA2 8QA Less <<
NCT00060567 Cancer Phase 1 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States Less <<
NCT00165594 Gastric Cancer Phase 1 Phase 2 Terminated(Study was completed... More >>.) Less << - Japan ... More >> Kashiwa, Chiba-prefecture, Japan, 277-0882 Sagamihara-shi, Kanagawa, Japan Takatsuki-shi, Osaka, Japan Sunto-gun, Shizuoka-prefecture, Japan, 411-0934 Chuo-ku, Tokyo, Japan, 104-0045 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.59mL

0.52mL

0.26mL

12.96mL

2.59mL

1.30mL

25.92mL

5.18mL

2.59mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories